Wockhardt has incorporated wholly owned subsidiary namely ‘Wockhardt Medicines’ (WML) with effect from March 25, 2019. The main object of WML is pharmaceuticals business is to carry on either as manufacturers, processors, traders, dealers, exporters, importers warehousing agents, commission agents etc.
The WML is incorporated with an Authorised Share Capital of Rs 10 lakh. The Company has subscribed to 100% shareholding comprising of 50,000 equity shares of Rs 10 each i.e. Rs 5 lakh in WML.
Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1858.70 |
Dr. Reddys Lab | 1258.55 |
Cipla | 1559.20 |
Lupin | 2198.25 |
Zydus Lifesciences | 1004.00 |
View more.. |